RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 3 filers reported holding RELAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $796,402 | -33.0% | 94,697 | 0.0% | 0.02% | -20.0% |
| Q2 2023 | $1,189,394 | -23.7% | 94,697 | 0.0% | 0.02% | -16.7% |
| Q1 2023 | $1,559,660 | +10.2% | 94,697 | 0.0% | 0.02% | +14.3% |
| Q4 2022 | $1,414,773 | -33.2% | 94,697 | 0.0% | 0.02% | -19.2% |
| Q3 2022 | $2,118,000 | +33.5% | 94,697 | 0.0% | 0.03% | +36.8% |
| Q2 2022 | $1,586,000 | -44.0% | 94,697 | 0.0% | 0.02% | -9.5% |
| Q1 2022 | $2,834,000 | -2.5% | 94,697 | 0.0% | 0.02% | +23.5% |
| Q4 2021 | $2,908,000 | -2.6% | 94,697 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $2,986,000 | -13.8% | 94,697 | 0.0% | 0.02% | -26.1% |
| Q2 2021 | $3,465,000 | +5.8% | 94,697 | 0.0% | 0.02% | -37.8% |
| Q1 2021 | $3,274,000 | -16.8% | 94,697 | 0.0% | 0.04% | -62.2% |
| Q4 2020 | $3,936,000 | -2.4% | 94,697 | 0.0% | 0.10% | -58.3% |
| Q3 2020 | $4,033,000 | – | 94,697 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,530,605 | $135,601,000 | 5.42% |
| Casdin Capital, LLC | 3,857,253 | $115,448,000 | 5.18% |
| Boxer Capital, LLC | 2,669,132 | $79,887,000 | 4.11% |
| Nextech Invest Ltd. | 475,485 | $14,231,000 | 4.06% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $835,196,000 | 3.96% |
| Integral Health Asset Management, LLC | 327,000 | $9,787,000 | 2.55% |
| EcoR1 Capital, LLC | 2,291,441 | $68,583,000 | 2.14% |
| Fernwood Investment Management, LLC | 185,063 | $5,539,000 | 1.94% |
| HARBOURVEST PARTNERS LLC | 296,402 | $8,871,000 | 1.81% |
| HARVARD MANAGEMENT CO INC | 541,124 | $16,196,000 | 1.64% |